Go back

Leo Pharma signs biomedical research deal

Denmark-based pharmaceutical company LEO Pharma has announced a research collaboration with the biomedical Scripps Research Institute in California. The focus of the collaboration will be to develop synthetic treatments for skin diseases, the company said on 15 July.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.